Scaling human microbiome data to unprecedented levels
BiomeSense has developed the first integrated technology solution to cost effectively automate, standardize, and scale human microbiome data collection and analysis.
join us
Overview
End-to-end solution
Our end-to-end technology solution is comprised of proprietary hardware, full laboratory services, and a time-series optimized bioinformatics platform. By massively scaling microbiome data generation, this unique three-pronged solution enables best-in-class data analysis across scientific disciplines facilitating unparalleled novel microbiome discovery.
Delivering Standardized,
Time-Series Data Routinely
Time-Series Data Routinely
Our novel technology was built from the ground up to make generating dense, time-series microbiome data routine and standardized
Turning Data Into Answers
Using proprietary, time-series optimized algorithms developed by leading bioinformatics experts, we translate microbiome data into actionable insights
Dramatically Reducing Costs
By eliminating expensive manual bottlenecks, our smart technology, in-house lab and end-to-end workflow solution reduce the costs of obtaining microbiome data by up to 90%
Dramatically Reducing Costs
By eliminating expensive manual bottlenecks, our smart technology, in-house lab and end-to-end workflow solution reduce the costs of obtaining microbiome data by up to 90%
Turning Data Into Answers
Using proprietary, time-series optimized algorithms developed by leading bioinformatics experts, we translate microbiome data into actionable insights
Delivering Standardized,
Time-Series Data Routinely
Time-Series Data Routinely
Our novel technology was built from the ground up to make generating dense, time-series microbiome data routine and standardized
Biosensor
Continuous, standardized sampling
BiomeSense has developed the first
fully automated Biosensor that enables efficient, low-cost collection and processing of dense, time-series gut microbiome samples.
fully automated Biosensor that enables efficient, low-cost collection and processing of dense, time-series gut microbiome samples.
BiomeSense has developed the first fully automated Biosensor that enables efficient, low-cost collection and processing of dense, time-series gut microbiome samples.
Once thought an impossible challenge, BiomeSense has made collecting dense, time-longitudinal microbiome data into a routine exercise—setting
the standard for any clinical trial incorporating human microbiome data. Appropriate for home or clinical use, our biosensor eliminates traditional patient adherence obstacles and dramatically lowers the per-sample cost of generating microbiome data. The result is continuous, standardized microbiome data comparable within and across studies.
the standard for any clinical trial incorporating human microbiome data. Appropriate for home or clinical use, our biosensor eliminates traditional patient adherence obstacles and dramatically lowers the per-sample cost of generating microbiome data. The result is continuous, standardized microbiome data comparable within and across studies.
Easy to Use and Mobile
The freestanding technology is designed to work almost anywhere, by anyone, requiring no user training. Needing only water and household electricity to run, it can be installed in a variety of locations—from a home bathroom to clinical site.
Fully-Automated,
Self-Contained Laboratory
Self-Contained Laboratory
By combining a simple interface for sample collection with advanced internal fluidics, nucleic acid extraction is performed immediately after receiving a sample, with no user input required. This standardizes the primary source of technical bias and enables continuous sampling.
Simple, Affordable Integration
into Any Clinical Study
into Any Clinical Study
Meeting the needs of today’s sophisticated clinical trials, the biosensor routinely and reliably delivers microbiome samples for analysis, eliminating the cost and headache of adding stool sample collection to a clinical study.
Laboratory
Sequencing performed
on every sample at no charge
on every sample at no charge
BiomeSense’s state-of-the-art laboratory is a critical part of our turnkey end-to-end solution to microbiome discovery. Staffed with experts in microbiome research, our in-house lab provides unparalleled expertise, convenience, and cost savings, giving us significant advantages over others in the industry. Most important, our in-house lab offers the reassurance that lab sequencing is being provided by specialists in the human microbiome.
Free Sequencing on Each Sample
Our laboratory costs are so low, all samples produced by the biosensor receive 16(S) rRNA sequencing at the BiomeSense lab at no cost. Shallow or deep shotgun sequencing is also available, at costs far below industry standard.
Standardized Results
All samples undergo the same sequencing process, standardizing results across any range of sample volume and allowing for cross-trial comparison.
The Convenience of
a Fully Integrated Lab
a Fully Integrated Lab
BiomeSense’s laboratory services are fully integrated into our pipeline, eliminating the need to invest precious time or money sourcing and managing laboratory services.
Bioinformatics
Revolutionary bioinformatics to turn data into discovery
Providing high-quality, dense data isn’t enough that data has to lead to answers. As the final stage of our integrated solution, we are developing a custom bioinformatics platform,
the first ever specifically designed to process
and analyze the unprecedented quantities
of time-series data produced by our pipeline.
the first ever specifically designed to process
and analyze the unprecedented quantities
of time-series data produced by our pipeline.
Providing high-quality, dense data isn’t enough
that data has to lead to answers. As the final stage
of our integrated solution, we are developing a custom bioinformatics platform, the first ever specifically designed to process and analyze the unprecedented quantities of time-series data produced
by our pipeline.
that data has to lead to answers. As the final stage
of our integrated solution, we are developing a custom bioinformatics platform, the first ever specifically designed to process and analyze the unprecedented quantities of time-series data produced
by our pipeline.
Over time, this platform will allow us to create the only standardized, time-series microbiome database in existence with the ability to analyze vast amounts of data within a trial and between trials. As this database grows, our vision is to open it to academic investigators worldwide, exploding microbiome innovation. This revolutionary approach ensures all data generated undergo best-in-class analytical techniques, designed and developed by the team behind the QIIME platform. These novel techniques are being created specifically for longitudinal microbiome investigations, dramatically improving the ability to discover, validate, and interpret microbiome-based discoveries.
Our team
Time-Series Optimized Algorithms
Advanced algorithms, developed by microbiome specialists and guided by our Scientific Advisory Board, provide the last step in our end-to-end solution—exceptional analysis of dense, time-series data, available to everyone we work with
The Future of Microbiome Innovation
Always looking toward the future, we have a vision that extends beyond supporting today’s research. As data is generated, our goal is to build a cross-trial, time-series database that is free and open — encouraging and accelerating novel microbiome discoveries.
Cross-Trial, Time-Series
Microbiome Data
Microbiome Data
BiomeSense’s coordinated workflow will enable standardized data aggregation and analysis at a scale not possible with existing techniques, creating the first cross-trial, time-series microbiome database.
Calling for
partners today
partners today
Collaborating with the world’s best to discover, develop, and deliver. Clinical partners are intrinsic to BiomeSense’s vision of advancing microbiome science. We are collaborating with the world’s best researchers, academic and industry, to deliver the high-quality, standardized microbiome data and analysis needed to turbocharge discovery.
join us